A small observational study associated high-flow nasal oxygen with improved oxygen-saturation measures. It did not isolate the respiratory effect of either sedative.
Forty high-anesthetic-risk patients underwent endobronchial ultrasound procedures with combined midazolam and propofol. Twenty received standard oxygen and twenty received high-flow nasal oxygen.
The high-flow group had smaller saturation drops, higher minimum oxygen saturation, and shorter recorded desaturation episodes under the study conditions.
Treatment allocation was observational, and a small single-center sample cannot establish uncommon-event safety. Oxygen saturation also does not directly quantify ventilation, airway patency, consciousness, or drug concentration.
The paper cannot establish that high-flow oxygen eliminates sedation risk or that midazolam alone caused observed desaturations. A forensic review should retain co-medication, airway interventions, oxygen delivery, and the full physiologic record. Favorable saturation readings should be interpreted alongside other monitoring rather than treated as proof of an uneventful sedation.
Original analysis of the supplied journal article, identified as PMC12853666.